Mads Nørregaard-Madsen

25+ years of experience in biotech and pharma. Co-founder of Nuevolution, bringing DNA-Encoded Library (DEL) technology from concept to world leading small molecule drug discovery platform. Wide experience in technology innovation, target discovery, data science and research informatics. Currently drives the integration of ML, AI and DEL technologies for small molecule research at Amgen.